4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001628280-22-026157
CIK 0001534120other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:01 PM ET
Size
5.5 KB
Accession
0001628280-22-026157
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-05+25,000→ 25,000 totalExercise: $3.97From: 2023-10-05Exp: 2032-10-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in full on October 5, 2023, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:01 PM ET
- Size
- 5.5 KB